Clinical trial

Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or…

NCT00471809 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Terminated

Key facts

NCT number NCT00471809
Title Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)
Official title Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)
Acronym MARS
Lead sponsor National Heart, Lung, and Blood Institute (NHLBI), NIH
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Asthma
Intervention type Drug
Interventions Budesonide + Salmeterol + Azithromycin, Budesonide + Salmeterol + Montelukast, Budesonide + Salmeterol + Placebo
Enrollment 210
Start date Mar 1, 2006
Completion Mar 1, 2007
First posted May 10, 2007
Last update posted Jul 29, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies